HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Douglas B Kell Selected Research

estropipate (Ogen)

1/2021SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19.
11/2020Is Porphyromonas gingivalis involved in Parkinson's disease?
7/2020Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes.
1/2019A Possible Role of Amyloidogenic Blood Clotting in the Evolving Haemodynamics of Female Migraine-With-Aura: Results From a Pilot Study.
1/2015The simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Douglas B Kell Research Topics

Disease

15Inflammation (Inflammations)
01/2022 - 01/2009
11Alzheimer Disease (Alzheimer's Disease)
01/2020 - 01/2013
8COVID-19
01/2022 - 01/2020
7Thrombosis (Thrombus)
01/2021 - 11/2018
7Parkinson Disease (Parkinson's Disease)
12/2020 - 04/2013
7Pre-Eclampsia (Preeclampsia)
01/2020 - 07/2008
6Infections
01/2022 - 11/2002
5Disease Progression
07/2020 - 04/2006
5Thrombophilia
01/2019 - 01/2015
4Type 2 Diabetes Mellitus (MODY)
11/2020 - 03/2015
4Dementia (Dementias)
11/2018 - 01/2016
3Neuroinflammatory Diseases
12/2020 - 11/2015
2Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2022
2Post-Acute COVID-19 Syndrome
01/2022 - 01/2021
2Dysbiosis
12/2020 - 01/2018
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2018 - 01/2018
2Necrosis
03/2012 - 02/2011
2Tuberculosis (Tuberculoses)
11/2002 - 11/2002
1Drug-Related Side Effects and Adverse Reactions
09/2021
1Thrombotic Microangiopathies
11/2020
1Nervous System Diseases (Neurological Disorders)
11/2020
1Periodontal Diseases (Periodontal Disease)
11/2020
1Cytokine Release Syndrome
07/2020
1Rheumatoid Arthritis
01/2020
1Mitochondrial Diseases (Mitochondrial Disease)
01/2020
1Ischemia
01/2020
1Acute-Phase Reaction
01/2019
1Migraine Disorders (Migraine)
01/2019
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2019
1Migraine with Aura (Familial Hemiplegic Migraine)
01/2019
1Huntington Disease (Huntington's Disease)
01/2019
1Multiple Organ Failure (MODS)
04/2018
1Sepsis (Septicemia)
04/2018
1Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
04/2018
1Prion Diseases (Transmissible Spongiform Encephalopathies)
04/2018
1Disseminated Intravascular Coagulation
04/2018
1Septic Shock (Toxic Shock Syndrome)
04/2018
1Communicable Diseases (Infectious Diseases)
01/2018
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2017
1Endotoxemia
01/2016
1Cognitive Dysfunction
01/2016
1Memory Disorders (Memory Loss)
11/2015

Drug/Important Bio-Agent (IBA)

16FibrinIBA
01/2022 - 06/2013
13IronIBA
12/2020 - 01/2009
11Amyloid (Amyloid Fibrils)IBA
01/2022 - 01/2017
10Biomarkers (Surrogate Marker)IBA
07/2020 - 04/2006
9Proteins (Proteins, Gene)FDA Link
01/2022 - 11/2002
9LipopolysaccharidesIBA
01/2022 - 11/2015
7Fibrinogen (Factor I)FDA Link
07/2020 - 05/2014
5AntioxidantsIBA
01/2022 - 01/2018
5estropipate (Ogen)FDA LinkGeneric
01/2021 - 01/2015
5Ferritins (Ferritin)IBA
11/2020 - 01/2013
4ErgothioneineIBA
01/2022 - 01/2018
4CytokinesIBA
01/2019 - 11/2015
3Transcription Factors (Transcription Factor)IBA
03/2012 - 12/2006
3NF-kappa B (NF-kB)IBA
02/2011 - 12/2006
2Pharmaceutical PreparationsIBA
09/2021 - 01/2016
2Oxygen (Dioxygen)IBA
01/2021 - 01/2020
2SynucleinsIBA
12/2020 - 04/2013
2P-SelectinIBA
11/2020 - 07/2020
2Gingipain Cysteine EndopeptidasesIBA
01/2020 - 01/2019
2Therapeutic UsesIBA
01/2020 - 01/2018
2Peptide Hydrolases (Proteases)FDA Link
01/2020 - 01/2019
2lipopolysaccharide-binding proteinIBA
01/2018 - 01/2018
2EndotoxinsIBA
01/2016 - 11/2015
2Chelating AgentsIBA
01/2016 - 01/2014
2Hydroxyl RadicalIBA
01/2015 - 01/2009
1Hemostatics (Antihemorrhagics)IBA
01/2022
1AutoantibodiesIBA
01/2022
1Nucleic AcidsIBA
12/2021
1Lipid Bilayers (Lipid Bilayer)IBA
09/2021
1muramyl- NAc- (pentapeptide)pyrophosphoryl- undecaprenolIBA
09/2021
1Antifibrinolytic Agents (Antifibrinolytics)IBA
01/2021
1SARS-CoV-2 spike proteinIBA
01/2021
1Coloring Agents (Dyes)IBA
11/2020
1fibrin fragment D (D-dimer)IBA
07/2020
1von Willebrand FactorIBA
07/2020
1VitaminsIBA
01/2020
1LactoferrinIBA
01/2020
1KynurenineIBA
01/2019
1EnzymesIBA
01/2019
1ProdrugsIBA
01/2019
1Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2019
1Kynurenine 3-Monooxygenase (Kynurenine 3 Monooxygenase)IBA
01/2019
1Amyloidogenic ProteinsIBA
01/2019
1Monoclonal AntibodiesIBA
11/2018
1thioflavin TIBA
11/2018
1PrionsIBA
04/2018
1VaccinesIBA
01/2018
1Anti-Bacterial Agents (Antibiotics)IBA
01/2018
1NeurograninIBA
07/2017
1GemcitabineFDA Link
01/2017
1NucleosidesIBA
01/2017
1ThrombinFDA Link
03/2015
1Interleukin-6 (Interleukin 6)IBA
01/2015

Therapy/Procedure

5Therapeutics
01/2021 - 04/2006
1Operative Surgical Procedures
01/2022
1Oral Hygiene (Dental Hygiene)
11/2020
1Precision Medicine
07/2020
1Resuscitation
01/2016